Featured patents

S. Agalactiae Antigens I and II
US 08449892 B2, May 28, 2013, Markus Horky et al. / Intercell AG (Vienna, AT)
An isolated hyperimmune serum-reactive antigen fragment consisting of amino acids…

Streptococcus Pyogenes Antigens and Corresponding DNA Fragments
US 08821895 B2, Sept. 2, 2014, Denis Martin et al. / ID Biomedical Corporation of Quebec (Laval, CA)
A chimeric polypeptide comprising one or more polypeptide fragments, wherein each…

Streptococcus Suis Vaccines and Diagnostic Tests
US 08728490 B2, May 20, 2014, Hilda Elizabeth Smith / Stichting Dienst Landbouwkundig Onderzoek (Wageningen, NL)
A recombinant Streptococcus suis serotype 1 knockout mutant, wherein…

Attenuated Live Vaccines for Aquatic Animals
US 08637049 B2, Jan. 28, 2014, Yuping Wei Pridgeon et al. / The United States of America, as represented by the Secretary of Agriculture (Washington, US)
An isolated attenuated Streptococcus iniae deposited with USDA ARS Patent…

Cna — B Domain Antigens in Vaccines Against Gram Positive Bacteria
US 08465751 B2, June 18, 2013, Guido Grandi et al. / Novartis AG (Basel, CH)
A Cna_B domain antigen selected from the group consisting of:…

Composition Comprising Sortase Anchored Surface Proteins of Streptococcus Uberis
US 08475809 B2, July 2, 2013, James Leigh / The University of Nottingham (Nottingham, GB)
An immunogenic composition comprising one or more of the Streptococcus uberis…

GAS57 Mutant Antigens and GAS57 Antibodies
US 08858957 B2, Oct. 14, 2014, Immaculada Margarit Y Ros et al. / Novartis AG (Basel, CH)
A method of raising an immune response against Streptococcus pyogenes…

Group B Streptococcus Polypeptides, Nucleic Acids and Therapeutic Compositions and Vaccines Thereof
US 08529912 B2, Sept. 10, 2013, Elizabeth Adderson et al. / St. Jude Children's Reseach Hospital (Memphis, US)
An isolated streptococcal Extracellular Matrix Adhesion Protein E (EmaE)…

Immunogenic Compositions for Streptococcus Pyogenes
US 08529913 B2, Sept. 10, 2013, Giuliano Bensi et al. / Novartis Vaccines and Diagnostics, SRL (Siena, IT)
An immunogenic composition comprising a combination of Streptococcus pyogenes…

Immunogenic Compositions for Gram Positive Bacteria Such as Streptococcus Agalactiae
US 08778358 B2, July 15, 2014, John Telford et al. / Novartis Vaccines and Diagnostics, Inc. (Emeryville, US)
An immunogenic composition comprising:…

Method for Controlling Streptococcus Pneumoniae Serotype 19A Polysaccharide Molecular Weight
US 08795689 B2, Aug. 5, 2014, Jean Heather Crinean / Wyeth LLC (New York, US)
A method for producing a solution containing high molecular weight isolated…

Method for Transforming a Bacterium Belonging to the Streptococcus Genus by Natural Competence
US 08663655 B2, March 4, 2014, Laetitia Fontaine et al. / Dupont Nutrition Biosciences APS (Copenhagen, DK)
An isolated peptide comprising at least 7 amino acids and at most 24 acids…

Method of Detoxification
US 08815254 B2, Aug. 26, 2014, Emmanuel Mertens et al. / GlaxoSmithKline Biologicals, S.A. (Rixensart, BE)
A process for reducing the haemolytic activity of pneumolysin, the process…

Multiple Antigenic Peptides Immunogenic Against Streptococcus Pneumonia
US 08642048 B2, Feb. 4, 2014, Scott E. Johnson et al. / The United States of America, as Represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention (Washington, US)
An isolated multiple antigenic peptide that immunospecifically binds…

Nucleic Acids and Proteins From Streptococcus Pneumoniae
US 08632784 B2, Jan. 21, 2014, Sean Bosco Hanniffy et al. / Sanofi Pasteur Limited (Toronto, Ontario, CA)
An isolated Streptococcus pneumoniae surface associated polypeptide…

Peptide Vaccines Against Group a Streptococci
US 08637050 B2, Jan. 28, 2014, Jacquelyn S. Sampson et al. / The United States of America, as represented by the Secretary, Department of Health and Human Services, Centers for Disease Control and Prevention (Washington, US)
A composition comprising a polypeptide comprising the amino acid sequence of SEQ…

Peptides Protective Against S. Pneumoniae and Compositions, Methods and Uses Relating Thereto
US 08445001 B2, May 21, 2013, Jutta Pikalo et al. / Intercell AG (Vienna, AT)
An isolated protective polypeptide consisting of the amino acid sequence of SEQ…

Protective Proteins of S. Agalactiae , Combinations Thereof and Methods of Using the Same
US 08795690 B2, Aug. 5, 2014, Barbara Maierhofer et al. / Valneva Austria GmbH (Vienna, AT)
A composition comprising a first protective protein and a second protective…

Protein-Based Streptococcus Pneumoniae Vaccine
US 08691243 B2, April 8, 2014, Yaffa Mizrachi Nebenzahl / Ben-Gurion University of the Negev Research and Development Authority (Beer Sheva, IL)
A method of inducing a protective immune response in a mammalian subject against…

Small Streptococcus Pyogenes Antigens and Their Use
US 08529911 B2, Sept. 10, 2013, Beatrice Senn et al. / Intercell Austria AG (Vienna, AT)
An isolated protein consisting…

Vaccine Against Group a Beta Hemolytic Streptococcus and Respective Process for Obtaining Thereof
US 08642049 B2, Feb. 4, 2014, Luiza Guilherme Guglielmi et al.
An immunogenic composition against group A beta hemolytic streptococcus…

Vaccine Comprising Recombinant CLPP Protein of Streptococcus Pneumoniae
US 08828409 B2, Sept. 9, 2014, Hyeok-Young Kwon et al. / Sungkyunkwan University (Seoul, KR)
A method for immunizing a human or animal against pneumococcal infections,…

Patentorg has 22 documents under Streptococcus Patents.

Other subcategories for category Drug, bio-affecting and body treating compositions
Quick navigation
New documents
  • Process for the Production of the Actinobacillus Pleuropneumoniae Toxins APXI or APXIII in a Liquid Culture Medium Under Supply of Air Enriched in Carbon Dioxide
  • Method for Manufacturing Nonvolatile Memory Device
  • Supply Chain Demand Satisfaction
  • Supply-Line Management Device
  • Storage Control Device and Method for Managing Snapshot